| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |